Cargando…
Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
• Data on caplacizumab use for thrombotic thrombocytopenic purpura (TTP) in Italy are missing. • Twenty-six Italian patients were treated with caplacizumab for an acute immune TTP episode. • Caplacizumab was effective in treating acute TTP in the Italian real-world clinical setting. • Two major blee...
Autores principales: | Agosti, Pasquale, De Leo, Pasqualina, Capecchi, Marco, Ferrari, Barbara, Mancini, Ilaria, Gattillo, Salvatore, Trisolini, Silvia Maria, Rinaldi, Erminia, Podda, Gian Marco, Prezioso, Lucia, Salutari, Prassede, Facchini, Luca, Caramazza, Domenica, Tolomelli, Giulia, Artoni, Andrea, Peyvandi, Flora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502422/ https://www.ncbi.nlm.nih.gov/pubmed/37720483 http://dx.doi.org/10.1016/j.rpth.2023.102185 |
Ejemplares similares
-
Caplacizumab for thrombotic thrombocytopenic purpura
Publicado: (2020) -
Caplacizumab for Acute Thrombotic Thrombocytopenic Purpura
por: Katsivalis, Katherine V., et al.
Publicado: (2021) -
Caplacizumab in adult patients with acquired thrombotic
thrombocytopenic purpura
por: Hanlon, Ashley, et al.
Publicado: (2020) -
Shared decision making, thrombotic thrombocytopenic purpura, and caplacizumab
por: Sukumar, Senthil, et al.
Publicado: (2020) -
Efficacy and safety of azathioprine during remission of immune-mediated thrombotic thrombocytopenic purpura
por: Bichard, Christian, et al.
Publicado: (2022)